Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study by Shaygannejad, V., Fayyazi, E., Badihian, S., Mirmosayyeb, O., Manouchehri, N., Ashtari, F., Asgari, N.

Get full text

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review by Mirmosayyeb, O., Ghaffary, E.M., Vaheb, S., Pourkazemi, R., Shaygannejad, V.

Get full text

Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis by Zobairy, H, Salem, M M, Ghajarzadeh, M, Mirmosayyeb, O, Mirsalehi, M

Get full text

Mesenchymal stem cell therapy in multiple sclerosis: An updated review of the current clinical trials by Mirmosayyeb, O, Meamar, R, Tanhaie, A.P, Eskandari, N, Shaygannejad, V

Get full text

Assessment of Coping Strategies in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Patients by Mahdi, Shaygannejad, V., Azarbayejani, R., Mirmosayyeb, O.

Get full text

Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire by Mirmosayyeb, Omid, Shaygannejad, Vahid, Ghajarzadeh, Mahsa

Get full text

Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence by Etemadifar, Masoud, Salari, Mehri, Mirmosayyeb, Omid, Serati, Mehdi, Nikkhah, Roham, Askari, Mozhde, Fayyazi, Emad

Get full text

Retraction: Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review

Get full text

P031 - Mesenchymal stem cell therapy in multiple sclerosis: An updated review of the current clinical trials by Mirmosayyeb, O., Meamar, R., Tanhaie, A.P., Eskandari, N., Shaygannejad, V.

Get full text

Incidence of Bell’s palsy after coronavirus disease (COVID-19) vaccination: a systematic review and meta-analysis by Atena Soltanzadi, Omid Mirmosayyeb, Amin Momeni Moghaddam, Hamed Ghoshouni, Mahsa Ghajarzadeh

Get full text